Tradestie Institutional Equity Comparison Engine · Market Close Nov 17, 2026
PLUR vs SRZN: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
SRZN Wins Head-to-Head Institutional Verdict (4–1 across 6 Pillars · 7–2 Matrix Metrics)
SRZN Overall Winner
6-Pillar Tally: PLUR 1 – 4 SRZN (1 Tie)
Matrix Metrics: PLUR 2 – 7 SRZN
As of Nov 17, 2026, Surrozen, Inc. Common (SRZN) is the stronger overall head-to-head candidate over Pluri Inc. (PLUR) in the Tradestie Institutional Equity Comparison Engine, winning 7–2 core matrix metrics and 4–1 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). PLUR carries a Unified Composite Score of 28.8/100 (SELL) at $0.98 (3.6x Forward P/E, -2454.5% operating margin), whereas SRZN carries 33.2/100 (SELL) at $30.16 (N/M Forward P/E, -485.4% operating margin).
- Defensive Composite Rating Caution: Although SRZN compares more favorably head-to-head, both PLUR (28.8/100 SELL) and SRZN (33.2/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model.
- Technical & Structure Timing Caution: PLUR is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 39.9); meanwhile SRZN trades in a Markup technical trend (CONSOLIDATION options phase, RSI 53.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Executive Snapshot Side-by-Side Composite Ratings & Technical Regime
Ask Alpha AI About PLUR vs SRZN
PLUR
Pluri Inc.
$0.98
-5.88% 1D
Market Cap
$15.1M
TTM Revenue
$1.0M
Forward P/E
3.6x
Beta / 30D Vol
0.79β · 102% Vol
Unified Composite Score
28.8
SELL
Tech 15.0
Fund 34.0
Flow 50.0
Mom 40.0
Weinstein Technical Phase
Markdown · Sell / avoid
SRZN
Head-to-Head Winner
Surrozen, Inc. Common
$30.16
-6.68% 1D
Market Cap
$602.5M
TTM Revenue
$11M
Forward P/E
N/M
Beta / 30D Vol
1.28β · 70% Vol
Unified Composite Score
33.2
SELL
Tech 50.0
Fund 34.0
Flow 65.0
Mom 40.0
Weinstein Technical Phase
Markup · Hold / add on dips
6-Pillar Scorecard Institutional Category Breakdown (PLUR 1 – 4 SRZN)
1. Valuation Multiples
PLUR
Forward P/E
3.6x
N/M
Trailing P/E
3.6x
N/M
PEG Ratio
N/M
N/M
EV / Revenue
44.6x
48.3x
2. Growth & Scale
SRZN
Revenue Growth (YoY)
-15.8%
+408.6%
Earnings Growth (YoY)
+0.0%
-37.0%
TTM Revenue (USD)
$1.0M
$11M
Market Cap
$15.1M
$602.5M
3. Profitability & Quality
SRZN
Gross Margin
44.6%
N/A
Operating Margin
-2454.5%
-485.4%
Net Profit Margin
0.0%
0.0%
Return on Equity (ROE)
-1022.0%
-62.8%
4. Balance Sheet & Cash Flow
SRZN
Cash Generation (TTM)
-$22M
-$31M
Cash Flow Margin
N/A
N/A
Net Cash / Leverage
$30M Net Debt
$95M Net Cash
Dividend Yield
None (0.00%)
None (0.00%)
5. Options & Positioning
SRZN
Options Structure Phase
UNCLASSIFIED
CONSOLIDATION
Current IV / %ile
N/A (N/A)
72.0% (5th %ile)
Put/Call OI Skew
N/A
N/A
OBV Trend / Tech Phase
NEUTRAL · Markdown
NEUTRAL · Markup
6. R&D & Supply-Chain Moat
Tie
OpEx & R&D Intensity
N/A
N/A
90D R&D Disclosures
0 papers
0 papers
Competitive Moat
Cyclical / Execution-Driven Positioning
Cyclical / Execution-Driven Positioning
Supply-Chain Role
Biotechnology Operator
Biotechnology Operator
Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table
Core Matrix Wins: PLUR (2) vs SRZN (7)| Institutional Metric | PLUR | SRZN | Criterion | Row Edge |
|---|---|---|---|---|
| Market Capitalization | $15.1M | $602.5M | SRZN | |
| Trailing P/E Ratio | 3.6x | N/M | PLUR | |
| Forward P/E Ratio | 3.6x | N/M | PLUR | |
| Revenue Growth (YoY) | -15.8% | +408.6% | SRZN | |
| Operating Margin (TTM) | -2454.5% | -485.4% | SRZN | |
| Net Profit Margin | 0.0% | 0.0% | Tie | |
| Return on Equity (ROE) | -1022.0% | -62.8% | SRZN | |
| 52-Week Range Position | 3% ($1–$5) | 70% ($12–$38) | SRZN | |
| Beta / 30D Volatility | 0.79β · 102% Vol | 1.28β · 70% Vol | SRZN | |
| Unified Institutional Score | 28.8 / 100 (SELL) | 33.2 / 100 (SELL) | SRZN | |
| Trailing 12M Revenue (USD) | $1.0M | $11M | Scale | |
| Gross Profit Margin (TTM) | 44.6% | N/A | Quality | |
| PEG Ratio & EV / Revenue | N/M PEG · 44.6x EV/Rev | N/M PEG · 48.3x EV/Rev | Valuation | |
| Cash Flow & Balance Sheet | -$22M ($30M Net Debt) | -$31M ($95M Net Cash) | Solvency |
Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)
1M Horizon
SRZN +11.37 pp
3M Horizon
SRZN +70.0 pp
6M Horizon
SRZN +79.11 pp
1Y Horizon
SRZN +207.0 pp
Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | PLUR Revenue | SRZN Revenue | PLUR Op. Margin | SRZN Op. Margin | Margin Leader |
|---|---|---|---|---|---|
| FY2018 | $0M | N/A | -67462.0% | N/A | PLUR |
| FY2019 | $0M | N/A | -65800.0% | N/A | PLUR |
| FY2020 | $0M | N/A | -128156.5% | N/A | PLUR |
| FY2022 | $0M | $10M | -17774.8% | -354.7% | SRZN |
| FY2023 | $0M | N/A | -9493.4% | N/A | PLUR |
| FY2024 | $0M | $10M | -6796.9% | -239.7% | SRZN |
| FY2025 | $0M | $0M | -1659.9% | -1210.6% | SRZN |
| FY2026 | $0M | N/A | -2454.5% | N/A | PLUR |
Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor
Live Options Phase Tracker
PLUR
UNCLASSIFIED
Current IV
N/A
IV Percentile
N/A
Put/Call OI Skew
N/A
IV Regime
Unclassified
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
Net Delta Signal
NEUTRAL
OBV Flow
NEUTRAL
Exact PLUR Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro.
Unlock 14-Day Free Trial →
SRZN
CONSOLIDATION
Current IV
72.0%
IV Percentile
5th %ile
Put/Call OI Skew
N/A
IV Regime
Compressed (<25th %ile)
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
Net Delta Signal
BULLISH
OBV Flow
NEUTRAL
Exact SRZN Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro.
Unlock 14-Day Free Trial →
Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity
Corporate R&D & Foundry Leaderboard
PLUR Moat Profile
Cyclical / Execution-Driven Positioning
Biotechnology Operator
OpEx & R&D Reinvestment
N/A
90D Engineering Disclosures
0 Published
SRZN Moat Profile
Cyclical / Execution-Driven Positioning
Biotechnology Operator
OpEx & R&D Reinvestment
N/A
90D Engineering Disclosures
0 Published
Investor FAQ PLUR vs SRZN Key Questions & Quantitative Answers
As of Nov 17, 2026, Surrozen, Inc. Common (SRZN) is the stronger overall head-to-head candidate over Pluri Inc. (PLUR) in the Tradestie Institutional Equity Comparison Engine, winning 7–2 core matrix metrics and 4–1 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). PLUR carries a Unified Composite Score of 28.8/100 (SELL) at $0.98 (3.6x Forward P/E, -2454.5% operating margin), whereas SRZN carries 33.2/100 (SELL) at $30.16 (N/M Forward P/E, -485.4% operating margin). Defensive Composite Rating Caution: Although SRZN compares more favorably head-to-head, both PLUR (28.8/100 SELL) and SRZN (33.2/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model. Technical & Structure Timing Caution: PLUR is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 39.9); meanwhile SRZN trades in a Markup technical trend (CONSOLIDATION options phase, RSI 53.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
SRZN leads the Growth & Scale pillar: PLUR posts -15.8% YoY revenue growth and +0.0% YoY earnings growth on $1.0M TTM revenue (44.6% gross margin, -2454.5% operating margin), compared with SRZN at +408.6% YoY revenue growth and -37.0% YoY earnings growth on $11M TTM revenue (N/A gross margin, -485.4% operating margin). Across the 8-period historical trajectory (FY2018 to FY2026), PLUR cumulative revenue shifted N/A while SRZN shifted +0.0%. In operating R&D and SG&A reinvestment, PLUR deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for SRZN.
PLUR screens cheaper on headline valuation multiples. PLUR trades at 3.6x Forward P/E, 3.6x Trailing P/E, N/M PEG, and 44.6x EV/Revenue (unreported FCF margin), whereas SRZN trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 48.3x EV/Revenue (unreported FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against PLUR (-1022.0% ROE) versus SRZN (-62.8% ROE) capital efficiency.
In options market volatility and institutional positioning, PLUR carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.79β · 102% Vol realized risk). By comparison, SRZN carries 72.0% implied volatility (5th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in a CONSOLIDATION options structure phase (1.28β · 70% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Launch Custom Ticker Comparison →
SRZN vs PLUR · Reverse Pair
PLUR vs PYPD
· Sector Peer
SRZN vs FTH
· Sector Peer
SRZN vs JSPR
· Sector Peer
SRZN vs TIL
· Sector Peer
INTC vs AMD
· x86 & Data Center CPU
NVDA vs AMD
· AI Accelerators
TSM vs ASML
· Foundry & Lithography
MSFT vs GOOGL
· Hyperscale Cloud & AI
AAPL vs META
· Consumer Ecosystem
LLY vs NVO
· GLP-1 Biopharma